16374
4-Bromobenzenesulfonamide
≥99.0% (T)
Sign In to View Organizational & Contract Pricing.
Select a Size
About This Item
Empirical Formula (Hill Notation):
C6H6BrNO2S
CAS Number:
Molecular Weight:
236.09
UNSPSC Code:
12352100
NACRES:
NA.22
PubChem Substance ID:
MDL number:
Beilstein/REAXYS Number:
2691657
Product Name
4-Bromobenzenesulfonamide, ≥99.0% (T)
InChI
1S/C6H6BrNO2S/c7-5-1-3-6(4-2-5)11(8,9)10/h1-4H,(H2,8,9,10)
SMILES string
NS(=O)(=O)c1ccc(Br)cc1
InChI key
STYQHICBPYRHQK-UHFFFAOYSA-N
assay
≥99.0% (T)
form
solid
functional group
bromo
Application
4-Bromobenzenesulfonamide was used as reagent in preparation of cobalt(III) complexes of N,R-sulfonyldithiocarbimate anion. It was also used in the synthesis of 2-, 3- and 4-(substituted-phenylethynyl)benzenesulfonamides.
General description
4-Bromobenzenesulfonamide is a metabolite of ebrotidine, a new H2-receptor antagonist.
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Preparation of novel cobalt (III) complexes with dithiocarbimates derived from sulfonamides.
Oliveira MRL and Bellis VMD.
Transition Metal Chemistry, 24(2), 127-130 (1999)
S Sentellas et al.
Electrophoresis, 22(1), 71-76 (2001-02-24)
This paper illustrates the possibilities of chemometric methods in the resolution and quantification of various compounds in overlapping peaks from capillary electrophoresis. Ebrotidine and most of its metabolites were efficiently separated by capillary zone electrophoresis (CZE) in a fused-silica capillary.
Gloria Uccello-Barretta et al.
Bioorganic & medicinal chemistry, 12(2), 447-458 (2004-01-16)
NMR spectroscopic and molecular modelling methods have been employed to describe the complexation of trans-N-4-[N'-(4-chlorobenzoyl)hydrazinocarbonyl]cyclohexylmethyl-4-bromobenzenesulfonamide, a new chemotype of NPY-5 antagonist, and beta-cyclodextrin, revealing the coexistence of two different kinds of 1:1 complexes where conformational changes of the guest compound
E Rozman et al.
Journal of pharmaceutical sciences, 83(2), 252-254 (1994-02-01)
Ebrotidine is a new H2-receptor antagonist which exhibits a remarkable ability for gastric mucosal protection. A preliminary metabolic pathway for this compound was proposed and the hypothetic metabolites were synthesized. The presence of ebrotidine and its metabolites ebrotidine S-oxide and
Raymond Anana et al.
Bioorganic & medicinal chemistry, 14(15), 5259-5265 (2006-04-26)
A group of regioisomeric phenylethynylbenzenesulfonamides possessing a COX-2 SO2NH2 pharmacophore at the para-, meta- or ortho-position of the C-1 phenyl ring, in conjunction with a C-2 substituted-phenyl (H, OMe, OH, Me, F) group, were synthesized and evaluated as inhibitors of
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service